Schedule 13G ownership disclosure

CYMABAY THERAPEUTICS INC

Security class unavailable · CUSIP: 23257D103

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,001,191
Percent of class
4.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001596770-16-000106
Form type
SC 13G/A
Filer
ALTA BIOPHARMA PARTNERS III LP
CIK
CIK 1257444
Filed
Feb 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub